BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 6608843)

  • 1. [Experience in using T-activin in multiple sclerosis patients].
    Gusev EI; Arion VIa; Aristova RA; Ivanokov AN; Tunkel' OI
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1984; 84(2):168-74. PubMed ID: 6608843
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical and immunologic effects of T-activin therapy in early stage melanoma patients.
    Stanojević-Bakić N; Milosević D; Vucković-Dekić L; Sasić M; Marković L
    Neoplasma; 1996; 43(4):245-52. PubMed ID: 8931749
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Functional properties of T-lymphocytes in patients with multiple sclerosis].
    Zleleznova TA; Ierusalimskiĭ AP
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1989; 89(7):19-23. PubMed ID: 2529722
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Results of clinico-immunological testing of myelopid in chronic forms of multiple sclerosis].
    Gusev EI; Demina TL; Boĭko AN; Popova NF; Stepanenko RN
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1992; 92(2):18-25. PubMed ID: 1326165
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [T-lymphocyte subpopulations in autoimmune and subacute thyroiditis treated with T-activin].
    Sakaeva NA; Balabolkin MI; Tabagari DZ
    Sov Med; 1989; (10):39-41. PubMed ID: 2617340
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Mechanism of formation of active T-rosette forming cells in multiple sclerosis patients].
    Matveeva TV; D'iakonova IN; Shaĭdullina FS
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1981; 81(2):21-5. PubMed ID: 6972132
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effect of using T-activin in the therapy of the newborn with suppurative surgical infection.
    Samsygin SA; Dolgina EN; Arion VYa ; Romanova LA; Shchevochkina GI; Ovchinnikova EA
    J Hyg Epidemiol Microbiol Immunol; 1989; 33(3):269-76. PubMed ID: 2809182
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Immunodiagnosis and immunotherapy of chronic nonspecific lung diseases].
    Borisova AM
    Ter Arkh; 1985; 57(3):62-6. PubMed ID: 3873720
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Use of T-activin in patients with sarcoidosis].
    Romanov VV; Khomenko IS; Ozerova LV; Gergert VIa
    Probl Tuberk; 1990; (4):15-7. PubMed ID: 2395843
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Status of local and general immunity in patients with multiple sclerosis].
    Totolian NA; Skoromets AA; Barbas IM; Smirnov AIu
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1991; 91(2):20-2. PubMed ID: 1647617
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunological dysfunctions in multiple sclerosis. I. Diminution of 'active' thymus-derived lymphocytes and presence of immunomodulating serum factors.
    Kateley JR; Bazzell SJ
    Clin Exp Immunol; 1979 Feb; 35(2):218-26. PubMed ID: 312171
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [T-cell immunity and immunomodulators in the comprehensive treatment of diffuse toxic goiter].
    Petunina NA; Balabolkin MI; Arion VIa
    Ross Med Zh; 1992; (5-12):19-24. PubMed ID: 1286263
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Thymus-dependent and thymus-independent blood lymphocytes in multiple sclerosis].
    Khondkarian OA; Gannushkina IV; Zavalishin IA; Zhirnova IG; Nevskaia OM
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1983; 83(3):32-6. PubMed ID: 6602442
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Comparative analysis of the use of levamisole and pyrogenal in the treatment of multiple sclerosis].
    Mukhtarova AA
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1985; 85(3):366-7. PubMed ID: 3873154
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A longitudinal study of immunological parameters in multiple sclerosis: cell-mediated immunity and complement profiles.
    Mar P; Gradl T; Dörner C; Contag I
    Clin Exp Immunol; 1979 Jun; 36(3):442-8. PubMed ID: 487645
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Immunocorrective therapy of pyelonephritis in children].
    Kirillov VI; Zernov NG; Arion VIa; Tebloeva LT; Riabchikov OP
    Urol Nefrol (Mosk); 1989; (5):17-21. PubMed ID: 2595860
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Immunity of middle age and aged patients with tuberculosis and its changes during multimodality treatment by using T-activin].
    Adambekov DA; Litvinov VI; Mambetov KB; Koshmuratov AG; Sabyrbekova TS
    Probl Tuberk; 1998; (5):46-8. PubMed ID: 9866400
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Clinico-immunologic correlations in disseminated sclerosis].
    Zavalishin IA; Khondkarian OA; Nevskaia OM; Pivovarova AI
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1984; 84(2):164-7. PubMed ID: 6608842
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Immunotherapy in the combined treatment of chronic destructive pulmonary tuberculosis].
    Ivanova LA
    Probl Tuberk; 1994; (3):16-9. PubMed ID: 7937662
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Increase in the efficacy of corticosteroid therapy in multiple sclerosis].
    Golovkin VI; Chikov Miu
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1985; 85(8):1131-4. PubMed ID: 3876669
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.